Posted by
20th Year Anniversary Milestone:  Announcing EBCI’s Disease Education, Awareness & Outreach Application

20th Year Anniversary Milestone: Announcing EBCI’s Disease Education, Awareness & Outreach Application

Hello.  It is unbelievable that the Chris Elliott Fund DBA End Brain Cancer Initiative (EBCI) is turning 20 years old THIS year!  I know this is a true reality but between you and I, how can that be? I am very proud of the work and the mission that EBCI has addressed head on and […]

Posted by
If The #’s Don’t Make Sense, The DREAM Has To…

If The #’s Don’t Make Sense, The DREAM Has To…

This year is all about the reality of running a 501(c)3 non-profit Advocacy organization from my perspective that directly and head-on meets the large unmet need that people, patients, caregivers and their family members will likely experience at the time of diagnosis and at the time or times of a recurrent or multiple recurrent brain […]

Posted by
LIVING Your Legend: by Dellann Elliott Mydland, Co-Founder, CEO, President & Board Chair

LIVING Your Legend: by Dellann Elliott Mydland, Co-Founder, CEO, President & Board Chair

I am proud to announce our new BLOG Post Series, titled “LIVING Your Legend” in honor of celebrating 20 years of living the mission. Today, while going through old patient and caregiver files dating all the way back to 2002, I honestly had a moment, actually more than a moment – have pretty much taken […]

Posted by
“Incisionless Surgery” Treatment Approach: Metabolic Targeting of GBM

“Incisionless Surgery” Treatment Approach: Metabolic Targeting of GBM

This month’s CURE MAG Cover Tip brought to you by the End Brain Cancer Initiative (EBCI), www.EndBrainCancer.org,  and through our patient advocacy and disease education partnership with CURE, focuses on turning Glioblastoma Multiforme (GBM) from a deadly disease into a chronic managed disease through turning GBM patients into cancer survivors through metabolic targeting of GBM […]

Posted by

The Importance of Shared Decision-Making for Patients With Glioblastoma

 Abstract: Navigating care for patients with cancer can be overwhelming considering the multiple specialists they encounter and the numerous decisions they must make. For patients with glioblastoma (GBM), management is further complicated by a poor prognosis, feelings of isolation, urgency to treat, and cognitive decline associated with this rare and progressive disease. For these reasons, […]

Posted by

Expanded Use of Innovative Brain Tumor Treatment Exemplified in GT Medical Technologies’ 2020 GammaTile® Therapy

To all our Supporters, Friends and Colleagues and especially to the Patients and Caregivers we serve and to the Healthcare Workers who tirelessly work on behalf of all of us! First of all, I want to take this opportunity to mark the passing of a momentous year and wish everyone a much better 2021. It […]

Posted by

KIYATEC – A potential game-changer in informing your brain tumor treatment decision

Hi guys!  I am extremely excited to share what I believe is groundbreaking news in the battle against brain cancer and other solid tumors. In this case, it’s a response-prediction test which improves outcomes by testing live cancer cells against a number of potential therapies to demonstrate which ones will be most effective in killing […]

Posted by

Today Would Have Been our 2020 Bellingham Brain Cancer Walk….

Today, May 31, 2020, the very last day of #BTAM month, I find myself reflecting on many things and just looked through the photos from last year’s Bellingham Brain Cancer WALK (BBCW) , Presenting Sponsor:  Novocure (www.novocure.com)  and am smiling and crying at the same time.  Just look at these photos!  What a super cool […]